BMC Medical Genomics

Table 5 Hypermethylated promoter in recurrent stone formers to cmpare gender and age

From: The correlation between promoter hypermethylation of VDR, CLDN, and CasR genes and recurrent stone formation

Gene	Female	Male	P-value
VDRa	9 (100%)	19 (90.5%)	0.483
VDRb	9 (100%)	19 (95.0%)	0.690
CLDNa	9 (100%)	14 (77.8%)	0.268
CLDNb	9 (100%)	14 (77.8%)	0.268
CasRa	8 (88.9%)	18 (94.7%)	0.575
CasRb	8 (88.9%)	18 (94.7%)	0.575

	Age < 60	Age ≥ 60	P-value
VDRa	22 (91.7%)	6 (100%)	0.634
VDRb	22 (95.6%)	6 (100%)	0.793
CLDNa	18 (81.8%)	5 (100%)	0.561
CLDNb	18 (81.8%)	5 (100%)	0.561
CasRa	20 (90.9%)	6 (100%)	0.611
CasRb	20 (90.9%)	6 (100%)	0.611

In 30 recurrent stone formers, 21 were male (70%) and 24 were under 60 (80%). Hypermethylated for each target locus are presented

Back to article page

ISSN: 1755-8794

Contact us

Submission enquiries: bmcmedicalgenomics@biomedcentral.com
General enquiries: ORSupport@springernature.com